Knockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer

scientific article published on 20 September 2016

Knockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3892/ETM.2016.3723
P932PMC publication ID5103714
P698PubMed publication ID27882085

P2093author name stringJie Pan
Xiaojie Wang
Pan Chi
Songfei Shen
Xingrong Lu
Yanwu Sun
Zongbin Xu
P2860cites workIs human kallikrein-11 in gastric cancer treated with surgery and adjuvant chemoradiotherapy associated with survival?Q44416612
Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancerQ48004808
Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.Q54369095
Colorectal cancerQ55924124
Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive TumorQ58614884
KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patientsQ62606052
Colorectal cancerQ84625527
Mechanisms of multidrug resistance in cancerQ84966118
Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 regionQ24290448
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialQ24647888
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Emerging roles of caspase-3 in apoptosisQ28141417
Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostateQ28204474
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancerQ28308193
MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosisQ33628432
Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosisQ33779488
Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosisQ34303405
Significance of human epidermal growth factor receptor 2 expression in colorectal cancerQ34585338
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancerQ34590724
Colorectal cancer statistics, 2014.Q34660408
Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma: a clinicopathological study of 230 casesQ34942792
Super-compact treatment with a high dose of moxifloxacin in patients with drug-resistant tuberculosis and its resistance mechanismsQ35159676
Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasisQ35162606
Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastasesQ35589315
Towards a pan-European consensus on the treatment of patients with colorectal liver metastasesQ36563821
Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/BaxQ36646046
Prognostic value and biological role of the kallikrein-related peptidases in human malignanciesQ37690308
Serum lactate dehydrogenase levels as a predictive marker of oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancerQ37730274
microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinomaQ39268741
Identification of HOXB8 and KLK11 expression levels as potential biomarkers to predict the effects of FOLFOX4 chemotherapyQ39424233
P433issue5
P921main subjectcolorectal cancerQ188874
oxaliplatinQ422327
P304page(s)2855-2860
P577publication date2016-09-20
P1433published inExperimental and Therapeutic MedicineQ23979083
P1476titleKnockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer
P478volume12

Reverse relations

cites work (P2860)
Q57790170Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns
Q64971114Kallikrein 12 Regulates Innate Resistance of Murine Macrophages against Mycobacterium bovis Infection by Modulating Autophagy and Apoptosis.
Q53705298Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell.